13F

Stock

Denali Therapeutics Inc.

DNLI · held by 2 managers

Reported value

$16.3M

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$144

Price effect on 1 books still in the name

Largest holder

$16.3M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC586K$16.3MHeld
Leonteq Securities AG50$1.39K−$144Cut−$1.37K

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.